News

Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update

Topline results for RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, expected in 4Q2025Enrollment continues in CHAPTER-3, a pivotal Phase 3 study of ...

Cabka H1 2025 Results on Track: Delivering on Key Milestones with Improved Visibility for H2

PRESS RELEASE Online investor presentation and Q&A at 11.00 CEST on 12 August 2025 via:Webinar| Cabka N.V. HY 2025 results ...
Sportico on MSN6d

WNBA CBA Meetings Resume Amid Investor Clamor for Sun Sale

Representatives from the WNBA and Women's National Basketball Players Association (WNBPA) reconvened this week in New York to continue collective bargaining negotiations after the last in-person ...